Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Bruch-Gerharz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Dermatology : EJD|May 5, 2007
Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapyDaniela Bruch-Gerharz, Michael Hertl, Thomas Ruzicka
Lancet (London, England)|April 24, 2007
Treating excessive sweating with poisonMonika Sonntag, Thomas Ruzicka, Daniela Bruch-Gerharz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005
[Nitric oxide in the pathogenesis of inflammatory dermatoses]Daniela Bruch-Gerharz, Thomas Ruzicka, Victoria Kolb-Bachofen
Dermatologie (Heidelberg, Germany)|November 5, 2024
[Skin and pregnancy]Daniela Bruch-Gerharz, Brigitte Stephan, Julia-Tatjana Maul
Dermatology (Basel, Switzerland)|January 10, 2008
Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patientPeter Arne Gerber, Klaus-Werner Schulte, Thomas Ruzicka, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: a novel clue to the pathogenesis of a rare syndromeDaniela Bruch-Gerharz, Claus-Dieter Gerharz, Helger Stege, et al.
JAMA|April 4, 2003
Cutaneous vascular malformations in disappearing bone (Gorham-Stout) diseaseDaniela Bruch-Gerharz, Claus-Dieter Gerharz, Helger Stege, et al.
The American Journal of Pathology|January 1, 2003
Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferationDaniela Bruch-Gerharz, Oliver Schnorr, Christoph Suschek, et al.
Wiener Klinische Wochenschrift|December 10, 2009
Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two casesPeter Arne Gerber, Edwin Bölke, Bettina Alexandra Buhren, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 9, 2008
Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximabEdwin Bölke, Peter Arne Gerber, Guido Lammering, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Dermatology : EJD|May 5, 2007
Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapyDaniela Bruch-Gerharz, Michael Hertl, Thomas Ruzicka
Lancet (London, England)|April 24, 2007
Treating excessive sweating with poisonMonika Sonntag, Thomas Ruzicka, Daniela Bruch-Gerharz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005
[Nitric oxide in the pathogenesis of inflammatory dermatoses]Daniela Bruch-Gerharz, Thomas Ruzicka, Victoria Kolb-Bachofen
Dermatologie (Heidelberg, Germany)|November 5, 2024
[Skin and pregnancy]Daniela Bruch-Gerharz, Brigitte Stephan, Julia-Tatjana Maul
Dermatology (Basel, Switzerland)|January 10, 2008
Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patientPeter Arne Gerber, Klaus-Werner Schulte, Thomas Ruzicka, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: a novel clue to the pathogenesis of a rare syndromeDaniela Bruch-Gerharz, Claus-Dieter Gerharz, Helger Stege, et al.
JAMA|April 4, 2003
Cutaneous vascular malformations in disappearing bone (Gorham-Stout) diseaseDaniela Bruch-Gerharz, Claus-Dieter Gerharz, Helger Stege, et al.
The American Journal of Pathology|January 1, 2003
Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferationDaniela Bruch-Gerharz, Oliver Schnorr, Christoph Suschek, et al.
Wiener Klinische Wochenschrift|December 10, 2009
Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two casesPeter Arne Gerber, Edwin Bölke, Bettina Alexandra Buhren, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 9, 2008
Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximabEdwin Bölke, Peter Arne Gerber, Guido Lammering, et al.
Pageof 2